• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名接受抗肿瘤坏死因子治疗患者的肺部苏尔加分枝杆菌感染及治疗

Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.

作者信息

van Ingen Jakko, Boeree Martin, Janssen Matthijs, Ullmann Erik, de Lange Wiel, de Haas Petra, Dekhuijzen Richard, van Soolingen Dick

机构信息

Department of Pulmonary Diseases, Radboud University, Nijmegen Medical Centre, and the Rijnstate Hospital in Arnhem, The Netherlands.

出版信息

Nat Clin Pract Rheumatol. 2007 Jul;3(7):414-9. doi: 10.1038/ncprheum0538.

DOI:10.1038/ncprheum0538
PMID:17599076
Abstract

BACKGROUND

A 54-year-old man with a 22-year history of rheumatoid arthritis and an 8-year history of chronic obstructive pulmonary disease presented with dyspnea on exertion, nonproductive cough and fatigue of 1 month's duration. His medication at presentation consisted of etanercept, azathioprine, naproxen and inhaled fluticasone and salbutamol.

INVESTIGATIONS

At presentation, the patient underwent physical examination, chest X-ray and high-resolution CT, blood tests, and bronchoalveolar lavage fluid analysis including auramine stains and gene sequence analysis of cultured Mycobacterium szulgai. The patient underwent minithoracotomy after 6 months, and bronchoalveolar lavage fluid analysis, culture and chest X-ray after 18 months. Further chest imaging and culture of sputum samples were performed another year later.

DIAGNOSIS

Pulmonary M. szulgai infection.

MANAGEMENT

Triple drug therapy with rifampicin, ethambutol hydrochloride and clarithromycin. Anti-tumor necrosis factor treatment was continued.

摘要

背景

一名54岁男性,有22年类风湿关节炎病史和8年慢性阻塞性肺疾病病史,出现劳力性呼吸困难、干咳和持续1个月的乏力。就诊时他正在使用的药物包括依那西普、硫唑嘌呤、萘普生以及吸入用氟替卡松和沙丁胺醇。

检查

就诊时,患者接受了体格检查、胸部X线和高分辨率CT检查、血液检查,以及支气管肺泡灌洗液分析,包括金胺染色和对培养的苏尔加分枝杆菌进行基因序列分析。6个月后患者接受了小开胸手术,18个月后进行了支气管肺泡灌洗液分析、培养和胸部X线检查。1年后进一步进行了胸部影像学检查和痰液样本培养。

诊断

肺部苏尔加分枝杆菌感染。

治疗

采用利福平、盐酸乙胺丁醇和克拉霉素三联药物治疗。继续进行抗肿瘤坏死因子治疗。

相似文献

1
Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.一名接受抗肿瘤坏死因子治疗患者的肺部苏尔加分枝杆菌感染及治疗
Nat Clin Pract Rheumatol. 2007 Jul;3(7):414-9. doi: 10.1038/ncprheum0538.
2
Pulmonary Infection Caused by Mycobacterium shinjukuense.新宿分枝杆菌引起的肺部感染
Ann Am Thorac Soc. 2015 Jun;12(6):958-9. doi: 10.1513/AnnalsATS.201503-124LE.
3
[Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].[一名年轻健康男性由偶然分枝杆菌引起的肺部分枝杆菌病]
Nihon Kokyuki Gakkai Zasshi. 2010 Nov;48(11):866-70.
4
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.未经治疗的肺部苏尔加分枝杆菌感染的九年病程
South Med J. 2010 Aug;103(8):828-30. doi: 10.1097/SMJ.0b013e3181e6cc26.
5
[A case of pulmonary infection caused by Mycobacterium szulgai].
Kekkaku. 2002 May;77(5):421-5.
6
[Pulmonary infection due to Mycobacterium szulgai, a group 2 nontuberculous mycobacterium].[由苏尔加分枝杆菌引起的肺部感染,一种2型非结核分枝杆菌]
Nihon Kokyuki Gakkai Zasshi. 2001 Dec;39(12):920-3.
7
[Two cases of Mycobacterium szulgai pulmonary disease in the elderly].[两例老年舒尔加伊分枝杆菌肺病]
Kekkaku. 2005 May;80(5):427-32.
8
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.标准化三联药物方案治疗非结核分枝杆菌肺部感染的疗效
Clin Infect Dis. 2008 Jul 15;47(2):222-4. doi: 10.1086/589250.
9
Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.一名接受抗TNFα(阿达木单抗)治疗的类风湿关节炎患者发生扁桃体结核。
Neth J Med. 2005 Mar;63(3):112-4.
10
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.尽管进行了化学预防,但接受抗TNF药物治疗的患者仍患结核病。
Int J Tuberc Lung Dis. 2006 Oct;10(10):1127-32.

引用本文的文献

1
Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.类风湿关节炎合并非结核分枝杆菌肺病患者的死亡率:一项回顾性队列研究。
PLoS One. 2020 Dec 2;15(12):e0243110. doi: 10.1371/journal.pone.0243110. eCollection 2020.
2
Treatment of Non-Tuberculous Mycobacterial Lung Disease.非结核分枝杆菌肺病的治疗
Curr Treat Options Infect Dis. 2016 Dec;8(4):275-296. doi: 10.1007/s40506-016-0086-4. Epub 2016 Oct 11.
3
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.
同床异梦:生物治疗时代的分枝杆菌和类风湿关节炎。
Nat Rev Rheumatol. 2013 Sep;9(9):524-31. doi: 10.1038/nrrheum.2013.82. Epub 2013 Jun 25.
4
Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.监测肺疾病和肺移植受者的非甾体免疫抑制剂:美国胸科医师学会循证临床实践指南。
Chest. 2012 Nov;142(5):e1S-e111S. doi: 10.1378/chest.12-1044.
5
Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.抗肿瘤坏死因子-α 治疗的延续是否对发生肺部分枝杆菌感染的患者是一种安全的选择?:病例报告和文献复习。
Clin Rheumatol. 2012 Feb;31(2):203-10. doi: 10.1007/s10067-011-1902-3. Epub 2011 Dec 15.
6
Nontuberculous mycobacteria and the lung: from suspicion to treatment.非结核分枝杆菌与肺部:从怀疑到治疗。
Lung. 2010 Aug;188(4):269-82. doi: 10.1007/s00408-010-9240-9. Epub 2010 Apr 9.
7
Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.非结核分枝杆菌感染与抗肿瘤坏死因子-α治疗。
Emerg Infect Dis. 2009 Oct;15(10):1556-61. doi: 10.3201/eid1510.090310.